Shruti D. Dave

Ahmedabad, GJ, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

ISOT Consensus Statement for the Kidney Transplant Recipient and Living Donor with a Previous Diagnosis of COVID-19.

ISOT Consensus Statement for the Kidney Transplant Recipient and Living Donor with a Previous Diagnosis of COVID-19.

Journal: Indian journal of nephrology

Published: March 13, 2021

NOTTO Transplant Specific Guidelines with Reference to COVID-19.

NOTTO Transplant Specific Guidelines with Reference to COVID-19.

Journal: Indian journal of nephrology

Published: June 23, 2020

In vitro differentiation of neural cells from human adipose tissue derived stromal cells.

In vitro differentiation of neural cells from human adipose tissue derived stromal cells.

Journal: Neurology India

Published: May 17, 2018

In vitro Generated Mesenchymal Stem Cells: Suitable Tools to Target Insulin Dependent Diabetes Mellitus?

In vitro Generated Mesenchymal Stem Cells: Suitable Tools to Target Insulin Dependent Diabetes Mellitus?

Journal: Current stem cell research & therapy

Published: September 06, 2016

Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus.

Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus.

Journal: Cytotherapy

Published: November 14, 2014

Co-infusion of donor adipose tissue-derived mesenchymal and hematopoietic stem cells helps safe minimization of immunosuppression in renal transplantation - single center experience.

Co-infusion of donor adipose tissue-derived mesenchymal and hematopoietic stem cells helps safe minimization of immunosuppression in renal transplantation - single center experience.

Journal: Renal failure

Published: September 24, 2014

Combined therapy of insulin-producing cells and haematopoietic stem cells offers better diabetic control than only haematopoietic stem cells' infusion for patients with insulin-dependent diabetes.

Combined therapy of insulin-producing cells and haematopoietic stem cells offers better diabetic control than only haematopoietic stem cells' infusion for patients with insulin-dependent diabetes.

Journal: BMJ case reports

Published: September 09, 2014

Pre-transplant co-infusion of donor-adipose tissue derived mesenchymal stem cells and hematopoietic stem cells may help in achieving tolerance in living donor renal transplantation.

Pre-transplant co-infusion of donor-adipose tissue derived mesenchymal stem cells and hematopoietic stem cells may help in achieving tolerance in living donor renal transplantation.

Journal: Renal failure

Published: December 19, 2013

Management of type 1 diabetes mellitus using in vitro autologous adipose tissue trans-differentiated insulin-making cells.

Management of type 1 diabetes mellitus using in vitro autologous adipose tissue trans-differentiated insulin-making cells.

Journal: BMJ case reports

Published: July 30, 2013

Infusion of autologous adipose tissue derived neuronal differentiated mesenchymal stem cells and hematopoietic stem cells in post-traumatic paraplegia offers a viable therapeutic approach.

Infusion of autologous adipose tissue derived neuronal differentiated mesenchymal stem cells and hematopoietic stem cells in post-traumatic paraplegia offers a viable therapeutic approach.

Journal: Advanced biomedical research

Published: June 19, 2013

Stable graft function on low-dose steroid monotherapy in spite of donor-specific antibodies in renal transplantation combined with stem cell infusion.

Stable graft function on low-dose steroid monotherapy in spite of donor-specific antibodies in renal transplantation combined with stem cell infusion.

Journal: BMJ case reports

Published: June 05, 2013

Co-infusion of adipose tissue derived mesenchymal stem cell-differentiated insulin-making cells and haematopoietic cells with renal transplantation: a novel therapy for type 1 diabetes mellitus with end-stage renal disease.

Co-infusion of adipose tissue derived mesenchymal stem cell-differentiated insulin-making cells and haematopoietic cells with renal transplantation: a novel therapy for type 1 diabetes mellitus with end-stage renal disease.

Journal: BMJ case reports

Published: May 28, 2013

Showing 1-12 of 21

Last Updated: 09/26/2026